NYSE:NTRNutrien Stock Price, Forecast & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NTR stock has decreased by 0.7% and is now trading at $31.76. View which stocks have been most impacted by Coronavirus.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 1 sell rating, 6 hold ratings, 13 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Nutrien.

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Nutrien.

Nutrien Ltd (NYSE:NTR) issued its quarterly earnings data on Wednesday, May, 6th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.08. The company had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $3.44 billion. Nutrien had a net margin of 4.49% and a return on equity of 4.66%. The firm's quarterly revenue was up 12.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.20 EPS. View Nutrien's earnings history.

Nutrien announced a quarterly dividend on Wednesday, May 6th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.45 per share on Friday, July 17th. This represents a $1.80 annualized dividend and a yield of 5.67%. The ex-dividend date is Monday, June 29th. View Nutrien's dividend history.

Nutrien issued an update on its FY20 earnings guidance on Wednesday, May, 6th. The company provided earnings per share guidance of $1.50-2.10 for the period, compared to the Thomson Reuters consensus estimate of $2.00.

21 analysts have issued twelve-month price targets for Nutrien's shares. Their forecasts range from $36.00 to $70.00. On average, they expect Nutrien's stock price to reach $49.30 in the next twelve months. This suggests a possible upside of 55.2% from the stock's current price. View analysts' price targets for Nutrien.

Media stories about NTR stock have trended somewhat positive on Sunday, according to InfoTrie. The research firm scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Nutrien earned a news impact score of 1.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Nutrien.

Nutrien saw a decline in short interest in the month of June. As of June 30th, there was short interest totaling 2,550,000 shares, a decline of 10.8% from the June 15th total of 2,860,000 shares. Based on an average daily trading volume, of 1,640,000 shares, the short-interest ratio is presently 1.6 days. Approximately 0.5% of the shares of the company are sold short. View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include Scotts Miracle-Gro (SMG), CF Industries (CF), Mosaic (MOS), Nufarm (NUF), American Vanguard (AVD), Marrone Bio Innovations (MBII), Calyxt (CLXT), CVR Partners (UAN), Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Eden Research (EDEN), Evogene (EVGN), China Green Agriculture (CGA), Bion Environmental Technologies (BNET) and SenesTech (SNES). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include General Electric (GE), Bank of America (BAC), Cimarex Energy (XEC), Johnson & Johnson (JNJ), Intel (INTC), AT&T (T), Exxon Mobil (XOM), Micron Technology (MU), Verizon Communications (VZ) and Pfizer (PFE).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a variety of retail and institutional investors. Top institutional investors include Hexavest Inc. (0.07%), Envestnet Asset Management Inc. (0.03%), PM CAPITAL Ltd (0.03%), Addenda Capital Inc. (0.02%), Cardinal Capital Management Inc. (0.00%) and Carroll Financial Associates Inc. (0.00%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Addenda Capital Inc., and Envestnet Asset Management Inc..

NTR stock was purchased by a variety of institutional investors in the last quarter, including PM CAPITAL Ltd, Cardinal Capital Management Inc., and Carroll Financial Associates Inc..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $31.76.

Nutrien has a market capitalization of $18.10 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]